Melanoidin treatments reduce several cucumber and tomato diseases in greenhouse tests

What the researchers tested

Melanoidins are a chemically varied group of nitrogen-containing compounds produced during the final stages of the Maillard reaction. Here, researchers prepared them by heating glucose and the amino acid glutamic acid together at 150°C. The findings concern this preparation, not every substance called a melanoidin.

The team studied cucumber damping-off, which kills seedlings, and cucumber downy mildew; tomato late blight, bacterial speck and bacterial canker; and tomato brown rugose fruit virus, or ToBRFV. The first three diseases involve oomycetes, organisms distinct from true fungi.

Plants grew in pots in greenhouses or net houses at one research institute. Researchers applied melanoidin solutions, generally at concentrations of 0.03% or 0.1%, either over the foliage or into the root zone. Some experiments were short; longer setups described as commercial-like used repeated weekly applications for roughly 9–11 weeks.

Damping-off, bacterial canker and virus experiments used deliberate pathogen exposure. Downy mildew, late blight and bacterial speck developed naturally. Researchers recorded seedling mortality or visible disease severity, with five to six replicates per treatment. They also calculated measures combining disease severity or mortality with its duration—effectively, the accumulated disease burden during an experiment. Statistical comparisons used analysis of variance followed by tests for differences between treatments.

What changed

The authors report statistically significant disease suppression across all six disease systems, although not every treatment worked equally well at every assessment.

For cucumber damping-off, sprays at 0.03% and 0.1% reduced the accumulated mortality measure by 52.2% and 62.7%, respectively, compared with untreated controls. These figures describe mortality over time, not percentage-point changes in the final number of dead seedlings.

Cucumber downy mildew also declined with sprays and drenches. In one longer experiment, only the 0.1% treatments still produced statistically significant reductions at day 71, with disease severity reduced by 51.8–53.1%. That result cautions against assuming the lower concentration will remain equally effective throughout a growing period.

For tomato late blight, four concentration-and-application combinations reduced accumulated disease burden by 51.9–85.5% in a longer experiment. Applications continued weekly; this does not demonstrate that one treatment protects plants for 11 weeks.

Tomato bacterial speck was reduced on both lower and upper leaves. In short experiments, the accumulated disease measure fell by 77.5–80.0% with 0.1% treatments and 51.1–61.9% with 0.03% treatments.

Bacterial canker results depended on the symptom and assessment date. Small necrotic spots were not significantly reduced at day eight, but were reduced at day eleven. Leaf-edge rot was also reduced by both application routes at the later assessment.

For ToBRFV, 0.1% treatments began three days before infection and continued on the infection day and eight days afterward. Accumulated symptom severity was reduced by 62.5% with drenching and 37.2% with spraying. Although drenching performed significantly better at the final assessment, the two routes did not differ significantly in the accumulated disease measure. This experiment therefore does not establish treatment of an already-established infection without prior application.

Does this show stronger plant immunity?

The authors interpret the findings as induced resistance: treatment activating the plant’s own defenses. They cite earlier work linking melanoidins to salicylic-acid signaling, a plant defense pathway. Those gene-expression and genetic experiments were not repeated across the diseases studied here.

One useful clue came from a culture-dish test. Melanoidins did not significantly reduce growth of the damping-off pathogen at the tested concentrations. That is consistent with an indirect protective effect, but does not prove the mechanism in plants or rule out direct effects against the other pathogens.

What remains uncertain

These are pot experiments in protected environments, not broad commercial field validation. The reported outcomes do not establish improved fruit yield or quality, prevention of virus transmission, or environmental safety. The virus-detection percentages also lack enough accompanying sampling detail to support a precise claim about reduced virus multiplication.

The manuscript contains reporting inconsistencies, including different species names for the late-blight pathogen in different sections. Such details need clarification.

The work is a bioRxiv preprint and has not been certified by peer review. Funding included Adama Agricultural Solutions and the Israel Innovation Authority; three authors disclose inventorship on related patent families. Overall, the study supports further testing of this melanoidin preparation—not a conclusion that it is already a proven replacement for existing disease management.